Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!

Product Image
Product Description

Designed specifically for the SpectraMax® i3 Multi-Mode Detection Platform, the field-upgradeable SpectraMax MiniMax™ 300 Imaging Cytometer option enables quick inspection of cells and provides insight into phenotypic changes that are important for understanding cytotoxicity, cell proliferation, and protein expression.

The SpectraMax® MiniMax™ 300 Imaging Cytometer option offers cellular imaging capability, and much more:

  • Simplified workflow: Cell and whole-well assays in a small footprint
  • No Stain Analysis: Eliminate cell staining for cell counting and confluency measurements using StainFree™ Technology
  • More data: Multi-parametric cell-based assays with brightfield and green and red fluorescent imaging
  • Familiar software: Set up, image and analyze cells in a snap using SoftMax® Pro Microplate Data Acquisition & Analysis Software
  • Higher sensitivity: Easily measure low cell concentration samples
  • Lower variance: Normalize your plate data to the number of cells in each well

The SpectraMax MiniMax™ 300 enables the following applications:

  • Cell Count/Viability
  • Cell Proliferation/Cytotoxicity
  • Marker Expression

Imaging cell-based assays typically requires the use of fluorescent probes that can be toxic to living cells or may require fixation. A label-free method for analyzing cell counts and cell confluence enables researchers to quantitatively monitor cell proliferation and health without time-consuming workflows that may disrupt cell viability.

The SpectraMax® i3 Multi-Mode Microplate Platform with MiniMax™ 300 Imaging Cytometer uses StainFree™ Cell Detection Technology so that you can perform cell proliferation, cytotoxicity, and other assays without fluorescent labels. For assays requiring multi-color detection and analysis, the SpectraMax MiniMax Imaging Cytometer now offers two channels of fluorescence, along with new cell analysis and classification methods.

This versatility is powered by SoftMax® Pro software with novel algorithms for object recognition providing multi-parametric outputs for a wide range of cell-based assays. An intuitive user interface lets even non-imaging specialists to get up and running quickly.

In our poster we demonstrate how this platform can be used to obtain more biologically relevant data. StainFree Technology enables cell counting comparable to fluorescent nuclear counts. IC50 curves for compound-treated cells obtained through StainFree analysis are presented. Cell viability assessment using the EarlyTox™ Cell Integrity assay plus
classification feature in SoftMax Pro software provide detailed information on compound
effects. Plate reader assays using luminescence or other detection modes of the
SpectraMax i3 platform can easily be combined with imaging cytometry to obtain more
information on the mechanisms of cell toxicity.

Click the more information link to register to download our poster and data sheet and imagine the possibilities.


Product SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!
Company Molecular Devices
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices
660 - 665 Eskdale Road Winnersh Triangle Wokingham Berkshire RG41 5TS

Tel: +44-118-944-8000
Fax: +44-118-944-8001

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos